EHA 2025 | Latest updates from the STARGLO trial of Glofit-GemOx vs R-GemOx in R/R DLBCL
Published June 16, 2025
Views 193 | Likes 0 | Comments 0
At a glance
Views
193
Likes
0
Comments
0
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
During the 30th European Hematology Association (EHA) Congress, the Lymphoma Hub was pleased to speak to Gareth Gregory, Monash University, Melbourne, AU. We asked about the latest updates from the STARGLO trial of glofitamab plus gemcitabine and oxaliplatin (Glofit-GemOx) vs rituximab plus gemcitabine and oxaliplatin …
- Published
- June 16, 2025
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.